Founded in 2001 in Shenzhen, The GTJA Investment Group (GIG) is the first asset manager that started the "Theme-Based Industry Investment Approach ". Focusing on healthcare industry, GIG has expanded from its roots in strategic investment to become a diverse asset management platform covering Merges & Acquisitions, Private Equity, Venture Capital and Angel Rounds of investment. GIG has assembled the largest professional team in China, with over 10 years of industry experience and deep understanding as well as accurate judgment of the healthcare industry and has built a healthcare industry investment eco platform to become one of the world's highly influential healthcare investment institutions.

With ¥20 billion Yuan of assets under management across 16 healthcare industry funds, The GTJA Investment Group has invested in over 130 companies - 60 of which are from the healthcare industry - and has taken more than 20 companies public. Amongst all, Boya Bio-Pharmaceutical (300294), still a holding company of GIG, is the leading enterprise in the domestic blood products industry.
关于我们 公司业务 核心竞争力 成功案例